SynCardia Systems, Inc.

/**/ P { margin-bottom: 0.08in; } /**/

SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart for use as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.

Content from this campaign

Health & Healthcare

SynCardia Provides Update Regarding Voluntary Recall of Potentially Affected Freedom® Portable Drivers
SynCardia Systems, Inc. today provided an update regarding the resolution of a recent voluntary recall of a limited number of its Freedom® portable drivers, following a related U.S. Food and Drug Administration (FDA) September 18, 2015 recall announcement.

Health & Healthcare

SynCardia Provides Update Regarding Voluntary Recall of Potentially Affected Freedom® Portable Drivers
SynCardia Systems, Inc. today provided an update regarding the resolution of a recent voluntary recall of a limited number of its Freedom® portable drivers, following a related U.S. Food and Drug Administration (FDA) September 18, 2015 recall announcement.

Health & Healthcare

Dan Hudspeth Joins SynCardia Systems, Inc. as Chief Financial Officer

More from SynCardia Systems, Inc.

SynCardia Systems, Inc.

SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE...

SynCardia Total Artificial Heart Patients in the News

Highest bridge to human heart transplant rate of any approved heart device, 79% Over 1,350 implants account for nearly 400 patient years on the...

SynCardia temporary Total Artificial Heart

The SynCardia Total Artificial Heart is the world's first & only FDA, Health Canada and CE approved Artificial Heart.

SynCardia Awards and Recognition

SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE...

SynCardia Systems, Inc. Regulatiory and Approvals

FDA, CE Mark and Health Canada Approvals of SynCardia Systems, Inc. Devices

SynCardia Total Artificial Heart Professional Papers

Professional Papers, Abstracts and Case Studies of the SynCardia temporary Total Artificial Heart around the globe.

Artificial Heart

For patients suffering from end-stage biventricular (both sides) heart failure, a donor heart transplant is the standard of care. However, not all...

Scholarships at SynCardia Systems, Inc.

The Anna Salazar Memorial Engineering Scholarship, funded by SynCardia Systems, Inc., seeks to support female University of Arizona College of...